Speed of Processing Training to Improve Cognition in Traumatic Brain Injury and Mild Cognitive Impairment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-12-12

Study Completion Date

2022-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to investigate the effectiveness of a technique designed to improve processing speed (i.e. the amount of time it takes to process information) in a Traumatic Brain Injury (TBI) population. The study is designed to study how well this technique can help people with TBI increase their processing speed and their ability to function better in everyday life.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Speed of Processing Training to Improve Cognition in Multiple Sclerosis

NCT02301260

Multiple Sclerosis

COMPLETED NA

Applying Speed of Processing Training to Individuals With Traumatic Brain Injury

NCT01838811

Traumatic Brain Injury

COMPLETED NA

Treating Cognitive Deficits in Traumatic Spinal Cord Injury (SCI)

NCT03985540

Spinal Cord Injuries

COMPLETED NA

Improving Time-Based Prospective Memory in TBI

NCT04065477

Traumatic Brain Injury

ACTIVE_NOT_RECRUITING NA

Cogmed for Working Memory After TBI

NCT02305212

Traumatic Brain Injury

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The current proposal is designed to apply this treatment protocol to a large sample of individuals with moderate to severe TBI with documented impairment in PS. The goals of the trial are to (a) test the efficacy of this treatment protocol within a TBI population, (b) evaluate the impact of the treatment on everyday functioning, (c) evaluate the longer-term efficacy of the treatment, and (d) examine the utility of booster sessions in facilitating longer-term treatment effects. Individuals with moderate to severe TBI, with documented impairment in PS, will be randomly assigned to a treatment group or a control group. Both groups will undergo baseline, immediate post-treatment and long-term follow-up assessment consisting of: (1) a standardized neuropsychological battery and (2) an assessment of global functioning examining the impact of the treatment on daily activities. This design will allow us to assess the efficacy of SPT in persons with TBI and evaluate its impact on everyday life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Traumatic Brain Injury Mild Cognitive Impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment Group

Computerized exercised will be administered on a laptop computer twice a week for 5 weeks (10 training sessions).

Group Type EXPERIMENTAL

Speed of Processing Training

Intervention Type BEHAVIORAL

Placebo control group

Computerized exercises will be administered on a laptop computer twice a week for 5 weeks (10 training sessions).

Group Type PLACEBO_COMPARATOR

Placebo Control

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.